首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1653943

生物銀行市場規模、佔有率和成長分析（按產品和服務、生物銀行類型、樣本類型、儲存類型、所有者、應用、最終用戶和地區）—產業預測 2025-2032

Biobanking Market Size, Share, and Growth Analysis, By Product &Service, By Biobanks Type, By Sample Type, By Storage Type, By Ownership, By Application, By End user, By Region - Industry Forecast 2025-2032

出版日期: 2025年02月09日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年生物銀行市場規模價值 720 億美元，預計將從 2024 年的 769 億美元成長到 2032 年的 1,301.6 億美元，預測期內（2025-2032 年）的複合年成長率為 6.8%。

生物銀行市場正在經歷顯著的成長，這得益於先進技術、資料分析和自動化，這些技術正在將傳統的生物銀行轉變為創新的虛擬平台。這種轉變迎合了不同類型的生物庫，如疾病特異性生物庫、人類生物庫、組織庫和血庫，從而增強了市場動態。退化性疾病的日益普及將進一步增加對生物銀行服務的需求。向虛擬生物庫的轉變將簡化流程，減少週轉時間，使研究人員能夠更有效率地工作，並最終提高生物庫的產生收入。此外，軟體公司正在積極開發解決方案以最佳化生物銀行流程，支援虛擬系統的廣泛採用。技術和需求的整合將在未來幾年推動生物銀行市場的顯著成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司詳細資訊
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Thermo Fisher Scientific Inc.（United States）
Merck KGaA（Germany）
QIAGEN NV（Netherlands）
Hamilton Company（United States）
Tecan Trading AG（Switzerland）
Becton, Dickinson and Company（BD）（United States）
Lonza Group AG（Switzerland）
Charles River Laboratories International, Inc.（United States）
BioLife Solutions, Inc.（United States）
Brooks Automation, Inc.（United States）
Greiner Bio-One International GmbH（Austria）
STEMCELL Technologies Inc.（Canada）
Chart Industries, Inc.（United States）
BioIVT（United States）
Firalis SA（France）
Celltex Therapeutics Corporation（United States）
Sigma-Aldrich Corporation（United States）
Hope Biosciences（United States）
54Gene（Nigeria）

結論和建議

簡介目錄

Product Code: SQMIG35H2200

Biobanking Market size was valued at USD 72.0 billion in 2023 and is poised to grow from USD 76.9 billion in 2024 to USD 130.16 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).

The Biobanking Market is experiencing significant growth, fueled by advanced technologies, data analytics, and automation that are evolving traditional biobanks into innovative virtual platforms. This transformation accommodates various types of biobanks, including disease-specific, human-based, tissue, and blood banks, which collectively strengthen market dynamics. Increasing prevalence of degenerative diseases further enhances the demand for biobanking services. The shift towards virtual biobanking streamlines processes, reducing turnaround times and allowing researchers to work more efficiently, ultimately enhancing revenue generation for biobanks. Additionally, software companies are actively developing solutions to optimize the biobanking process, supporting the widespread adoption of virtual systems. This convergence of technology and demand positions the Biobanking Market for substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biobanking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biobanking Market Segments Analysis

Global Biobanking Market is segmented by Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user and region. Based on Product &Service, the market is segmented into Equipment, Consumables, Services and Software. Based on Biobanks Type, the market is segmented into Physical/Real Biobanks, Tissue Biobanks, Population Based Biobanks, Genetic (DNA/RNA), Disease Based Biobanks and Virtual Biobanks. Based on Sample Type, the market is segmented into Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids and Human Waste Products. Based on Storage Type, the market is segmented into Manual Storage and Automated Storage. Based on Ownership, the market is segmented into Universities, National/Regional Agencies, Non-Profit Organizations and Private Organizations. Based on Application, the market is segmented into Regenerative Medicine, Life Science Research and Clinical Research. Based on End user, the market is segmented into Pharmaceutical, Biotechnology Companies and CROs, Academic, Research Institutes and Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biobanking Market

One of the primary catalysts for the biobanking market is the swift advancement in genomics research and the rise of personalized medicine. As researchers deepen their comprehension of genetic markers and the intricacies of disease progression, the necessity for biobanks that preserve high-quality biosamples for genomic studies becomes increasingly prominent. These biosamples are crucial for the development of targeted therapies, which are essential in the realm of personalized medicine. Consequently, biobanking plays a pivotal role in shaping the future of healthcare, highlighting its significance in supporting cutting-edge research and innovative treatment strategies tailored to individual patients.

Restraints in the Biobanking Market

The biobanking market faces significant constraints stemming from ethical and legal considerations related to the collection, storage, and utilization of biospecimens. Key concerns include patient privacy, the processes of obtaining informed consent, and the potential for sensitive information to be misappropriated. These challenges create obstacles for biobanks as they strive to navigate regulatory requirements while maintaining public trust. The necessity to balance operational goals with the protection of individual rights and data confidentiality can hinder the growth and development of biobanks, as they must work within a complex legal landscape while ensuring ethical standards are upheld.

Market Trends of the Biobanking Market

The biobanking market is witnessing a significant trend towards the integration of artificial intelligence (AI) and big data analytics, revolutionizing how biosamples are managed and utilized. This technological advancement enhances specimen tracking, streamlines data management, and ensures superior quality in specimen storage. By employing AI-driven analytics, biobanks can sift through extensive biosample datasets to uncover valuable patterns and insights, thereby accelerating biomarker discovery and expediting drug development timelines. As researchers increasingly leverage these tools, the biobanking sector is positioned to unlock new opportunities in personalized medicine and innovation, ultimately driving growth and evolution within the healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Biobanking Market Size by Product &Service & CAGR (2025-2032)

Market Overview
Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
Services
- Storage Services
- Processing Services
- Transport Services
- Supply Services
Software

Global Biobanking Market Size by Biobanks Type & CAGR (2025-2032)

Market Overview
Physical/Real Biobanks
Tissue Biobanks
Population Based Biobanks
Genetic (DNA/RNA)
Disease Based Biobanks
Virtual Biobanks

Global Biobanking Market Size by Sample Type & CAGR (2025-2032)

Market Overview
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products

Global Biobanking Market Size by Storage Type & CAGR (2025-2032)

Market Overview
Manual Storage
Automated Storage

Global Biobanking Market Size by Ownership & CAGR (2025-2032)

Market Overview
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations

Global Biobanking Market Size by Application & CAGR (2025-2032)

Market Overview
Regenerative Medicine
Life Science Research
Clinical Research

Global Biobanking Market Size by End user & CAGR (2025-2032)

Market Overview
Pharmaceutical
Biotechnology Companies and CROs
Academic
Research Institutes
Hospitals

Global Biobanking Market Size & CAGR (2025-2032)

North America (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- US
- Canada
Europe (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product &Service, Biobanks Type, Sample Type, Storage Type, Ownership, Application, End user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan Trading AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brooks Automation, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greiner Bio-One International GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioIVT (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Firalis S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltex Therapeutics Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hope Biosciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
54Gene (Nigeria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments